Susanne Merkel

Friedrich-Alexander-Universität Erlangen-Nürnberg — Germany

Medicine · Health Sciences

50h-index14.3kcitations304works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Surgical Treatments(129), Colorectal and Anal Carcinomas(87), Gastric Cancer Management and Outcomes(61), Colorectal Cancer Treatments and Studies(50), Colorectal Cancer Screening and Detection(38)

Publications299 total

Immune Cell-Specific and Isoform-Selective Regulation of CD44 in Pancreatic Ductal Adenocarcinoma Links Lymph Node Variant Loss and Exosomal CD44 to Clinical Outcome in Pancreatic Ductal Adenocarcinoma
Cells·2026Open Access
Pretreatment MRI versus postoperative pathology in locoregional staging of rectal cancer
Deutsches Ärzteblatt international·2026
The liver talks back: NPY orchestrates attraction of cancer cells and CHK2-dependent clonogenicity in the metastatic niche
Proceedings of the National Academy of Sciences·2025Open Access
Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the <scp>NFκB</scp> pathway
Molecular Oncology·2025Open Access
The Prognostic Role of Para-Aortic Lymph Node Metastasis in Patients with Resected Pancreatic Adenocarcinoma
Cancers·2025Open Access
Integrin β6 expression in colorectal cancer cells promotes liver metastasis through enhanced adhesion to endothelial fibronectin
Universität Zürich, ZORA·2025Open Access
Die histopathologische Tumorregression als Prognosefaktor beim neoadjuvant radiochemotherapierten Rektumkarzinom unter Anwendung eines modifizierten Dworak Grading-Systems
Zeitschrift für Gastroenterologie·2025
Author response for "Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the &lt;scp&gt;NFκB&lt;/scp&gt; pathway"
2025
Integrin β6 expression in colorectal cancer cells promotes liver metastasis through enhanced adhesion to endothelial fibronectin
International Journal of Cancer·2025· 1 citedOpen Access
Standardization of the surgical technique and reporting for radical right colectomy with central vascular ligation and complete mesocolic excision (RRoC-STAR): Delphi consensus
BJS Open·2025· 4 citedOpen Access
Abstract 6431: Endothelial SPARCL1 suppresses colorectal cancer metastases through dormancy induction and EMT inhibition in colonizing tumor cells
Cancer Research·2025
Increased Herpesvirus Entry Mediator Expression on Circulating Monocytes and Subsets Predicts Poor Outcomes in Pancreatic Ductal Adenocarcinoma Patients
International Journal of Molecular Sciences·2025Open Access
Exosomal CD40, CD25, and Serum CA19-9 as Combinatory Novel Liquid Biopsy Biomarker for the Diagnosis and Prognosis of Patients with Pancreatic Ductal Adenocarcinoma
International Journal of Molecular Sciences·2025· 3 citedOpen Access
<scp>AMIGO2</scp> characterizes cancer‐associated fibroblasts in metastatic colon cancer and induces the release of paracrine active tumorigenic secretomes
The Journal of Pathology·2024· 2 citedOpen Access
CD71 expressing circulating neutrophils serve as a novel prognostic biomarker for metastatic spread and reduced outcome in pancreatic ductal adenocarcinoma patients
Scientific Reports·2024· 6 citedOpen Access
Hat die Primärtumorlokalisation einen Einfluss auf die Langzeitprognose beim nicht fernmetastasierten Kolonkarzinom?
Zeitschrift für Gastroenterologie·2024
Multizentrische Rebefundungsstudie prätherapeutisches MRT vs. postoperative Pathologie zum Staging des Rektumkarzinoms bei nicht vorbehandelten Patienten auf Grundlage der OCUM-Studie
Zeitschrift für Gastroenterologie·2024
Cell cycle regulation by p21 in CD4+ T cells mediates anti-tumor response to colorectal cancer
Zeitschrift für Gastroenterologie·2024
Neutrophil-to-Lymphocyte Ratio and Prognostic Nutritional Index Are Predictors for Overall Survival after Primary Pancreatic Resection of Pancreatic Ductal Adenocarcinoma: A Single Centre Evaluation
Cancers·2024· 6 citedOpen Access
Biomarker-stratified first-line treatment of right-sided metastatic colon cancer with interdisciplinary collaboration in the IVOPAK II trial
Anti-Cancer Drugs·2024
page 1 of 15Next →

Frequent Co-authors

Werner Hohenberger(19), Werner Hohenberger(13), P. Hermanek(8), Robert Grützmann(7), Roland S. Croner(7), Theofilos Papadopoulos(6), Rainer Fietkau(5), Christian Wittekind(5), Arndt Hartmann(5), Klaus Weber(5), J. Göhl(5), Vera Schellerer(5), Carol Geppert(4), Klaus E. Matzel(4), Thomas Brunner(4), Thomas Meyer(4), Thomas Papadopoulos(4), R. Ruppert(4), Joachim Straßburg(4), J. Sauer(4)